Spliced X-Box Binding Protein 1 Couples the Unfolded Protein Response to Hexosamine Biosynthetic Pathway
Artículo
Publication date
2014-03-13Metadata
Show full item record
Cómo citar
Wang, Zhao V.
Cómo citar
Spliced X-Box Binding Protein 1 Couples the Unfolded Protein Response to Hexosamine Biosynthetic Pathway
Author
- Wang, Zhao V.;
- Deng, Yingfeng;
- Gao, Ningguo;
- Pedrozo Cibils, Zully;
- Li, Dan L.;
- Morales, Cyndi R.;
- Criollo Céspedes, Alfredo;
- Luo, Xiang;
- Tan, Wei;
- Jiang, Nan;
- Lehrman, Mark A.;
- Rothermel, Beverly A.;
- Lee, Ann Hwee;
- Lavandero González, Sergio;
- Mammen, Pradeep P .A.;
- Ferdous, Anwarul;
- Gillette, Thomas G.;
- Scherer, Philipp E.;
- Hill, Joseph A.;
Abstract
The hexosamine biosynthetic pathway (HBP) generates
uridine diphosphate N-acetylglucosamine
(UDP-GlcNAc) for glycan synthesis and O-linked
GlcNAc (O-GlcNAc) protein modifications. Despite
the established role of the HBP in metabolism and
multiple diseases, regulation of the HBP remains
largely undefined. Here, we show that spliced X-box
binding protein 1 (Xbp1s), the most conserved signal
transducer of the unfolded protein response (UPR),
is a direct transcriptional activator of the HBP. We
demonstrate that the UPR triggers HBP activation
via Xbp1s-dependent transcription of genes coding
for key, rate-limiting enzymes. We further establish
that this previously unrecognized UPR-HBP axis
is triggered in a variety of stress conditions. Finally,
we demonstrate a physiologic role for the UPR-HBP
axis by showing that acute stimulation of Xbp1s in
heart by ischemia/reperfusion confers robust cardioprotection
in part through induction of the HBP.
Collectively, these studies reveal that Xbp1s couples
the UPR to the HBP to protect cells under stress.
General note
Artículo de publicación ISI
Patrocinador
This work was supported by grants from the National
Institutes of Health (NIH) (HL-080144, HL-0980842, and HL-100401 to
J.A.H.; DK-55758, DK-088761, and DK-099110 to P.E.S.; GM-038545 to
M.A.L.; HL-102478-02 to P.P.A.M.; and HL-072016 and HL-097768
to B.A.R.), the Cancer Prevention Research Institute of Texas (CPRIT)
(RP110486P3), the American Heart Association (AHA) DeHaan Foundation
(0970518N), and the Fondation Leducq (11CVD04), and the Comision Nacional
de Investigacio´ n Cientifica y Tecnologica de Chile (FONDAP 15130011 to S.L.,
Z.P., and A.C.; Redes 120003 to S.L. and J.A.H.). Z.V.W. was supported by a
postdoctoral fellowship from the AHA (10POST4320009). Y.D. was supported
by a postdoctoral fellowship from the American Diabetes Association (ADA)
(7-08-MN-53). Z.P. was supported by a postdoctoral fellowship from
the Fondo Nacional de Desarrollo Cientı´fico y Tecnolo´ gico, FONDECYT
(3110039). A.C. was supported by The PEW Latin American Fellows Program
in Biomedical Science.
Identifier
URI: https://repositorio.uchile.cl/handle/2250/121941
DOI: dx.doi.org/10.1016/j.cell.2014.01.014
Quote Item
Cell 156, 1179–1192, March 13, 2014
Collections